SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

A Leerink downgrade and reduced outlook have put Bristol Myers pipeline and growth prospects in focus, with concerns around upcoming trial readouts and Cobenfy adoption. The cautious view contrasts with bullish posts highlighting positive multiple-myeloma data and Camzyos expanded pediatric indication.

Arbitrum is one of the leading Ethereum scaling solutions bringing cheap transactions to tens of thousands of users in an environment that feels very similar to Ethereum. It is an optimistic rollup and the leading L2 in terms of TVL. Some of the largest dApps live on Arbitrum include GMX, Radiant, Uniswap V3, and Gains Network.

Arbitrum

Robinhoods use of Arbitrum for its chain and tokenized-asset activity is the main catalyst traders cite for ARBs rally, alongside expectations that growing network activity could generate more revenue. Optimists see that adoption as a long-term positive, while skeptics argue ARB holders may not benefit without stronger token value capture and remain wary of token unlocks.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta Personals rollout, including ACH-enabled banking features and Visa Direct/Bivo Cash payment integrations, is driving attention as traders weigh the projects push into on-chain fiat and payments. Bulls view the launches as evidence of progress, while skeptics say sustained network usage and volume are still needed to validate the story amid volatile price action.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

STRKs sharp rally and breakout are driving attention, with traders linking the move to Starknets post-quantum security, privacy features and Bitcoin DeFi, as well as speculation about a possible shift toward an independent Layer 1. Momentum-driven optimism and FOMO are tempered by concerns about profit-taking, token-supply pressure and a potential pump-and-dump.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

AEROs sharp rally has traders focused on the planned AerodromeVelodrome merger and multichain expansion, including an Ethereum mainnet rollout, which the community expects could broaden liquidity and revenue. Bullish posts highlight the expansion and a potential break above the psychological $1 level, while others question whether the catalyst is already priced in or could prompt a sell-the-news reaction.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

CAN-2409s prostate-cancer trial results and additional biomarker findings are driving attention, alongside Candels stated plan to submit a BLA in Q4 2026. Traders are divided between optimism about the data and skepticism over the muted share-price response, filing timeline, cash needs, and CEO share sales.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Kodiaks positive Phase 3 data for its wet-AMD drug intensified competition concerns and weighed on Ocular Therapeutix. Bulls argue AXPAXLIs SOL-1 durability results and planned NDA filing could distinguish it, while skeptics question how well those results will translate into adoption and against rival treatments.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck and Modernas personalized mRNA melanoma vaccine met key Phase 3 endpoints when combined with Keytruda, lifting optimism about Mercks oncology pipeline and the potential to strengthen its franchise ahead of Keytrudas patent expiration. Traders are largely bullish on the validation, though some question how much the results justify in valuation given that full data, overall-survival results and regulatory progress remain outstanding.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers recent climb and renewed turnaround discussion are drawing attention, with traders pointing to oncology pipeline and product progress, analyst upgrades, and the dividend as support for the recovery case. Bulls see improving momentum beyond COVID products, while skeptics remain concerned about resistance to further gains and upcoming patent expirations.

Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is drawing attention as a low-cost, broad U.S. market fund for long-term, buy-and-hold investing, with traders praising diversification and steady accumulation. That optimism contrasts with warnings about market-wide risksincluding high valuations, rising yields, and geopolitical uncertaintyand debate over whether index funds offer enough protection from a downturn.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

SMTB News